Interferons and Their Use in Persistent Viral Infections
- 1 January 2009
- book chapter
- Published by Springer Nature
- Vol. 189 (189) , 203-241
Abstract
In 2007, the world celebrated the 50th anniversary of the discovery of interferon (IFN) by Isaacs and Lindenmann. Subsequently, the IFN-α gene was cloned, fully sequenced and IFN-α was produced in recombinant form. Recombinant IFN-α is now used as the basis for treatment of chronic hepatitis C virus infection and can also be used to treat certain forms of chronic hepatitis B virus infections. IFNs have also been used in other viral infections, although with less success. The antiviral mechanisms of IFNs are reviewed in this chapter as well as the utility of IFNs in the treatment of persistent viral infections.Keywords
This publication has 208 references indexed in Scilit:
- Interferon modulation of cellular microRNAs as an antiviral mechanismNature, 2007
- Effect of interferon-lambda on replication of hepatitis B virus in human hepatoma cellsVirus Research, 2007
- TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activityNature, 2007
- The effect of pegylated interferon-α on the treatment of lamivudine resistant chronic HBeAg positive hepatitis B virus infectionJournal of Hepatology, 2006
- Evasion of intracellular host defence by hepatitis C virusNature, 2005
- Long‐term follow‐up of peginterferon and lamivudine combination treatment in HBeAg‐positive chronic hepatitis B†Hepatology, 2005
- The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responsesNature Immunology, 2004
- Interferons and ApoptosisJournal of Interferon & Cytokine Research, 2003
- Ribavirin treatment for chronic hepatitis D: a pilot studyLiver International, 1994
- Treatment of Chronic Non-A, Non-B Hepatitis with Recombinant Human Alpha InterferonNew England Journal of Medicine, 1986